R. Urbaschek

1.5k total citations
57 papers, 1.2k citations indexed

About

R. Urbaschek is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, R. Urbaschek has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 14 papers in Epidemiology and 9 papers in Oncology. Recurrent topics in R. Urbaschek's work include Immune Response and Inflammation (31 papers), Sepsis Diagnosis and Treatment (10 papers) and Alcohol Consumption and Health Effects (7 papers). R. Urbaschek is often cited by papers focused on Immune Response and Inflammation (31 papers), Sepsis Diagnosis and Treatment (10 papers) and Alcohol Consumption and Health Effects (7 papers). R. Urbaschek collaborates with scholars based in Germany, United States and Switzerland. R. Urbaschek's co-authors include B. Urbaschek, Robert S. McCuskey, Patricia A. McCuskey, J. Bommer, Axel R. Heller, Susanne Heller, Helmut K. Seitz, Felix Stickel, Daniela N. Männel and Roland Schmidt and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and Annals of the New York Academy of Sciences.

In The Last Decade

R. Urbaschek

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Urbaschek Germany 23 395 282 247 184 171 57 1.2k
Étienne Dupont Belgium 16 631 1.6× 732 2.6× 289 1.2× 212 1.2× 158 0.9× 38 1.8k
Kazuyoshi Hanasawa Japan 20 408 1.0× 497 1.8× 182 0.7× 209 1.1× 207 1.2× 45 1.1k
M I Halliday United Kingdom 22 249 0.6× 281 1.0× 533 2.2× 365 2.0× 361 2.1× 45 1.6k
Mohamed Béjaoui Tunisia 23 445 1.1× 402 1.4× 286 1.2× 311 1.7× 77 0.5× 132 1.9k
B. Urbaschek Germany 19 344 0.9× 215 0.8× 115 0.5× 195 1.1× 64 0.4× 77 937
H J Hodgson United Kingdom 20 230 0.6× 636 2.3× 452 1.8× 175 1.0× 77 0.5× 58 1.4k
Károly Mészáros United States 19 373 0.9× 272 1.0× 110 0.4× 298 1.6× 88 0.5× 35 1.2k
Elio Gulletta Italy 25 206 0.5× 398 1.4× 304 1.2× 385 2.1× 111 0.6× 69 1.9k
David Oliveira United Kingdom 26 835 2.1× 212 0.8× 209 0.8× 290 1.6× 424 2.5× 89 2.1k
Hideo Hosotsubo Japan 21 348 0.9× 301 1.1× 180 0.7× 357 1.9× 164 1.0× 49 1.2k

Countries citing papers authored by R. Urbaschek

Since Specialization
Citations

This map shows the geographic impact of R. Urbaschek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Urbaschek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Urbaschek more than expected).

Fields of papers citing papers by R. Urbaschek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Urbaschek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Urbaschek. The network helps show where R. Urbaschek may publish in the future.

Co-authorship network of co-authors of R. Urbaschek

This figure shows the co-authorship network connecting the top 25 collaborators of R. Urbaschek. A scholar is included among the top collaborators of R. Urbaschek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Urbaschek. R. Urbaschek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Golling, M., Hamidreza Fonouni, Morva Tahmasbi Rad, et al.. (2008). Reduced glutathione in the liver as a potential viability marker in non–heart-beating donors. Liver Transplantation. 14(11). 1637–1647. 9 indexed citations
2.
Nimsky, Christopher, et al.. (2008). Untersuchungen zum Endotoxingehalt von Phytopharmaka: Korrelation zu klinisch beobachteten Nebenwirkungen. DMW - Deutsche Medizinische Wochenschrift. 113(3). 83–87. 4 indexed citations
3.
Golling, M., Cosima Jahnke, Hamidreza Fonouni, et al.. (2007). Distinct Effects of Surgical Denervation on Hepatic Perfusion, Bowel Ischemia, and Oxidative Stress in Brain Dead and Living Donor Porcine Models. Liver Transplantation. 13(4). 607–617. 13 indexed citations
4.
Echtenacher, Bernd, et al.. (2003). Treatment of experimental sepsis-induced immunoparalysis with TNF. Immunobiology. 208(4). 381–389. 28 indexed citations
5.
Stickel, Felix, R. Urbaschek, Detlef Schuppan, et al.. (2001). Serum Collagen Type VI and XIV and Hyaluronic Acid as Early Indicators for Altered Connective Tissue Turnover in Alcoholic Liver Disease. Digestive Diseases and Sciences. 46(9). 2025–2032. 41 indexed citations
6.
Schmeck, Joachim, et al.. (2000). Impact of endothelin-1 in endotoxin-induced pulmonary vascular reactions. Critical Care Medicine. 28(8). 2851–2857. 18 indexed citations
7.
Golling, M., Arianeb Mehrabi, T Kraus, et al.. (2000). Intramucosal pH and serum endotoxin concentrations as early predictive parameters for primary nonfunction after experimental liver transplantation. Transplantation Proceedings. 32(7). 2537–2538. 2 indexed citations
8.
Golling, M., Moritz von Frankenberg, Frank Ulrich, et al.. (2000). Intramucosal pH and liver endotoxin clearance during experimental liver transplantation. Transplant International. 13(0). S600–S604. 2 indexed citations
9.
Pelz, Klaus, et al.. (2000). Inflammatory consequences of the translocation of bacteria and endotoxin to mesenteric lymph nodes. The American Journal of Surgery. 180(1). 65–72. 22 indexed citations
10.
Heller, Axel R., Joachim Schmeck, Susanne Heller, et al.. (2000). Endothelin-1 impairs neutrophil respiratory burst and elimination of Escherichia coli in rabbits. Critical Care Medicine. 28(5). 1515–1521. 8 indexed citations
11.
Golling, M., Moritz von Frankenberg, Frank Ulrich, et al.. (2000). Intramucosal pH and liver endotoxin clearance during experimental liver transplantation. Transplant International. 13(S1). S600–S604. 2 indexed citations
12.
Ito, Yoshiya, et al.. (2000). BILIARY OBSTRUCTION EXACERBATES THE HEPATIC MICROVASCULAR INFLAMMATORY RESPONSE TO ENDOTOXIN. Shock. 14(6). 599–604. 23 indexed citations
13.
Volz, Joachim, et al.. (1996). Pathophysiologic features of a pneumoperitoneum at laparoscopy: A swine model. American Journal of Obstetrics and Gynecology. 174(1). 132–140. 94 indexed citations
14.
Nishida, Jiro, et al.. (1995). Role of endotoxin in the hepatic microvascular inflammatory response to ethanol. Journal of Gastroenterology and Hepatology. 10(S1). S18–23. 39 indexed citations
15.
Nishida, Jiro, et al.. (1994). ETHANOL EXACERBATES HEPATIC MICROVASCULAR DYSFUNCTION, ENDOTOXEMIA, AND LETHALITY IN SEPTIC MICE. Shock. 1(6). 413–418. 21 indexed citations
16.
Eguchi, Hiroshi, et al.. (1990). In vivo microscopy of the liver following acute administration of ethanol.. PubMed. 325. 341–50. 4 indexed citations
17.
Urbaschek, R. & B. Urbaschek. (1990). The Mediation of Endotoxin-Induced Beneficial Effects by Cytokines. Advances in experimental medicine and biology. 256. 549–556. 4 indexed citations
18.
Urbaschek, R. & B. Urbaschek. (1987). Tumor Necrosis Factor and Interleukin 1 as Mediators of Endotoxin-Induced Beneficial Effects. Clinical Infectious Diseases. 9(Supplement_5). S607–S615. 34 indexed citations
19.
Bommer, J., et al.. (1987). No evidence for endotoxin transfer across high flux polysulfone membranes.. PubMed. 27(6). 278–82. 51 indexed citations
20.
Urbaschek, R. & B. Urbaschek. (1982). Aspects of beneficial endotoxin-mediated effects. Journal of Molecular Medicine. 60(14). 746–748. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Étienne Dupont Breakdown of academic impact, for papers by Kazuyoshi Hanasawa Breakdown of academic impact, for papers by M I Halliday Breakdown of academic impact, for papers by Mohamed Béjaoui Breakdown of academic impact, for papers by B. Urbaschek Breakdown of academic impact, for papers by H J Hodgson Breakdown of academic impact, for papers by Károly Mészáros Breakdown of academic impact, for papers by Elio Gulletta Breakdown of academic impact, for papers by David Oliveira Breakdown of academic impact, for papers by Hideo Hosotsubo
Rankless by CCL
2026